Analysis of glycemic management among inpatients with diabetes in non-endocrinology department

Corresponding author: zhou qiang, zhouqiang8004@163.com

DOI: 10.12201/bmr.202410.00016

•  

  Abstract: Objective To assess the glycemic management of inpatients with diabetes in non-endocrinology department and discover the problems, so as to provide basis for the improvement of glycemic management. Methods　The inpatients diagnosed with diabetes in non-endocrine department from January 1, 2022 to December 31, 2022 were selected. The first page of medical records, doctors advices, laboratory test, and blood glucose monitoring data were collected. The detection rate and process indexes of glycemic management (detection rate of HbA1c, FBG, peripheral blood glucose test, diabetes-related dietary advices and consultation) in non-endocrine department were calculated. Three models of population, patient and patient-day model were used to evaluate the outcome of glycemic management, combined with the incidence of ideal blood glucose, hyperglycemia and hypoglycemia. The differences of process and outcome indicators between surgical and non-surgical patients were compared. Results 91.23% of inpatients with diabetes were in non-endocrinology department. The total detection rate of diabetes in non-endocrinology was 11.83%. The detection rate of HbA1c, FBG, peripheral blood glucose was 60.29%, 89.91% and 88.85%, respectively. 85.59% of patients had diabetes-related dietary advices, and 31.21% of the patients had consultations. The detection rate of HbA1c in surgical group was lower than that in non-surgical group (P < 0.001). The rate of FBG test and diabetes-related dietary advices in surgical group were higher than that in non-surgical group (P < 0.001). The rate of ideal blood glucose, severe hyperglycemia and hypoglycemia differed significantly across the three models (P < 0.001). In the population and patient-day model, the rate of ideal blood glucose in the surgical group was higher than that in the non-surgical group (P < 0.001), and the incidence of severe hyperglycemia in the surgical group was lower than that in the non-surgical group (P < 0.001). Conclusion The detection rate of inpatients with diabetes in non-endocrinology department was high. There are differences between surgical and non- surgical patients in quality indicators of glycemic management. It is necessary to carry out hospital-wide glycemic management to improve the quality and homogeneity of glycemic management.

  Key words: Diabetes; Inpatients; Glycemic management; Non-endocrinology

  Submit time: 8 October 2024

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• LIU Rui, LIU Xiao-li, JIN Ze-hong. Analysis of application value and related factors for left ventricular? global longitudinal strain in early cardiac function injury in patients with diabetes mellitus. 2024. doi: 10.12201/bmr.202411.00042

  zhangshipei, chujinshen, xueguohui, wanfang, caojunda, chenkeqi, chenjing, liuxiaofeng, chenxueli. Elevated HE4 levels in type 2 diabetes patients are associated with proteinuria and renal impairment. 2024. doi: 10.12201/bmr.202409.00008

  chenquan, hu hongpu. Construction of Mobile Health Intervention Strategy for Elderly Diabetes Patients Based on Behavior. 2020. doi: 10.12201/bmr.202005.00245

  Chuxin, HeYan, LiNana. Influencing factors of foot self-care behavior in diabetic patients: a Meta-analysis. 2024. doi: 10.12201/bmr.202408.00046

  ZHANG Xiao-juan. Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital. 2023. doi: 10.12201/bmr.202311.00002

  Wanyanli. Investigation and analysis of health knowledge awareness among elderly diabetic patients in Dongcheng District, Beijing. 2022. doi: 10.12201/bmr.202207.00039

  nijianing, zhoushuyan, zhangtingting, caixudong. Observation on the Clinical Application of Integrative Medicine in the Management of Non-dialysis Patients with Stage 3-5 Chronic Kidney DiseaseXIE Wenjia,NI Jianing,ZHOU Shuyan,ZHANG Tingting,CAI Xudong. 2024. doi: 10.12201/bmr.202409.00065

  Liu Yanan, Zhan Ming, Han Fei. Research Progress and Prospects of Finerenone in the Treatment of Diabetic Nephropathy. 2024. doi: 10.12201/bmr.202410.00033

  Liu Shiwei. The predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in the type 2 diabeticnephropathy. 2024. doi: 10.12201/bmr.202408.00066

  YU CAIGUO, FU YING. . 2024. doi: 10.12201/bmr.202407.00057

• ID	Submit time	Number	Download
  1	2024-09-12	bmr.202410.00016V1	Download

• Public  Anonymous  To author only Submit Comments